{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:25:21Z","timestamp":1794983121771,"version":"4.9.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["81970627"],"award-info":[{"award-number":["81970627"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82370688"],"award-info":[{"award-number":["82370688"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82400988 to LW"],"award-info":[{"award-number":["82400988 to LW"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Insulin resistance, adiposity, kidney dysfunction, and cardiovascular disease are closely interconnected in middle-aged and older adults and are central to the cardiovascular-kidney-metabolic (CKM) framework. Triglyceride-glucose (TyG)-related indices combine routine lipid, glucose, and anthropometric information, but their cross-population consistency and incremental prognostic value for mortality-risk assessment remain uncertain. We analyzed harmonized participant-level data from National Health and Nutrition Examination Survey (NHANES), English Longitudinal Study of Ageing (ELSA), China Health and Retirement Longitudinal Study (CHARLS), and Health and Retirement Study (HRS), with HRS used as a sensitivity cohort. Eligible participants were aged\u2005\u2265\u200550 years, had follow-up beyond baseline, available mortality status, and complete data for 7 TyG-related indices. Cohort-specific Cox models estimated associations of standardized TyG, TyG-body mass index, TyG-waist circumference, TyG-waist-to-height ratio, TyG-weight-adjusted waist index (WWI), TyG-a body shape index (ABSI), and TyG-body roundness index with all-cause mortality. Nonlinearity, proportional-hazards assumptions, sensitivity analyses, NHANES heart disease mortality, incremental prediction, and survival machine learning with external validation were further assessed. The primary analytic sample included 21,044 NHANES participants, 5454 ELSA participants, and 11,157 CHARLS participants, among whom 5566, 116, and 1393 deaths occurred during follow-up, respectively. The HRS sensitivity cohort included 4103 participants and 484 deaths. In fully adjusted Cox models, all 7 TyG-related indices were associated with higher all-cause mortality in NHANES, with the strongest associations observed for TyG-ABSI (hazard ratio [HR] 1.159, 95% confidence interval [CI] 1.115\u20131.205) and TyG-WWI (HR 1.155, 95% CI 1.113\u20131.199). In CHARLS, TyG-ABSI was positively associated with mortality (HR 1.088, 95% CI 1.029\u20131.151), whereas estimates in ELSA were imprecise. In HRS sensitivity analyses, TyG-WWI and TyG-ABSI remained positively associated with mortality. Adding TyG-related indices to a clinical Cox prediction framework produced only minimal absolute gains in discrimination. The final TyG-ABSI extreme gradient boosting survival model yielded 5-year time-dependent area under the curves of 0.808 in the NHANES internal test set and 0.760 in CHARLS. A research-use web calculator was developed for 5-year and 8-year mortality-risk estimation. TyG-ABSI and TyG-WWI were the most consistent TyG-related body shape markers of all-cause mortality across international aging cohorts. Although TyG-ABSI supported externally validated survival prediction, its incremental predictive value beyond established clinical and CKM variables was limited. These findings suggest that TyG-related body shape indices may serve primarily as interpretable, low-cost CKM risk markers rather than standalone prediction tools.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051089","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:02:22Z","timestamp":1792173742000},"page":"e51089","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["TyG-ABSI and TyG-WWI as insulin-resistance body shape markers of mortality in middle-aged and older adults within the cardiovascular-kidney-metabolic framework"],"prefix":"10.1097","volume":"105","author":[{"given":"Fangping","family":"Xiao","sequence":"first","affiliation":[{"name":"Center for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Department of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Qu","sequence":"additional","affiliation":[{"name":"Center for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-0121","authenticated-orcid":false,"given":"Chunsun","family":"Dai","sequence":"additional","affiliation":[{"name":"Center for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020.","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","article-title":"Prevalence of the cardiovascular-kidney-metabolic syndrome in the United States.","volume":"83","author":"Minhas","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages among middle-aged and older adults in China.","volume":"5","author":"Zhang","year":"2025","journal-title":"JACC Asia"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp.","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis.","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","article-title":"Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome.","volume":"24","author":"Yue","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12933-025-02921-3","article-title":"Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0-3: findings from two prospective cohorts.","volume":"24","author":"Chen","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12933-026-03116-0","article-title":"Comprehensive evaluation of triglyceride glucose index-a body shape index (TyG-ABSI) for incident peripheral artery disease: data-driven phenotyping and machine learning-based risk prediction in the UK Biobank.","volume":"25","author":"Zhao","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"R11-20261118","first-page":"1","article-title":"National Health and Nutrition Examination Survey: plan and operations, 1999\u20132010.","author":"Zipf","year":"2013","journal-title":"Vital Health Stat 1"},{"key":"R12-20261118","first-page":"1","article-title":"National Health and Nutrition Examination Survey: analytic guidelines, 1999\u20132010.","author":"Johnson","year":"2013","journal-title":"Vital Health Stat 2"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS).","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/ije\/dys168","article-title":"Cohort profile: the English longitudinal study of ageing.","volume":"42","author":"Steptoe","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ije\/dyu067","article-title":"Cohort profile: the health and retirement study (HRS).","volume":"43","author":"Sonnega","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ije\/dyz032","article-title":"Accounting for missing data in statistical analyses: multiple imputation is not always the answer.","volume":"48","author":"Hughes","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker.","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/bimj.200610301","article-title":"Consistent estimation of the expected Brier score in general survival models with right-censored event times.","volume":"48","author":"Gerds","year":"2006","journal-title":"Biom J"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models.","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12933-024-02120-6","article-title":"The association between TyG and all-cause\/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999-2018.","volume":"23","author":"Yao","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12933-025-03057-0","article-title":"Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: evidence from international multi-cohort studies.","volume":"25","author":"Li","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","article-title":"Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study.","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-025-02689-6","article-title":"The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies.","volume":"24","author":"Tan","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12933-025-02880-9","article-title":"Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts.","volume":"24","author":"Zhao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12933-025-02940-0","article-title":"Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with cardiovascular-kidney-metabolic syndrome: evidence from two large national population-based studies.","volume":"24","author":"Tan","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-026-03109-z","article-title":"The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies.","volume":"25","author":"Lin","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-026-03119-x","article-title":"Association of the C-reactive protein-triglyceride-glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies.","volume":"25","author":"Jin","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"e2415051","DOI":"10.1001\/jamanetworkopen.2024.15051","article-title":"Body roundness index and all-cause mortality among US adults.","volume":"7","author":"Zhang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics.","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation.","volume":"35","author":"Steyerberg","year":"2014","journal-title":"Eur Heart J"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0272989X14547233","article-title":"Calibration of risk prediction models: impact on decision-analytic performance.","volume":"35","author":"Van Calster","year":"2015","journal-title":"Med Decis Making"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:02:24Z","timestamp":1794981744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051089"}},"subtitle":["A multi-cohort observational study with external survival-model validation"],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":34,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051089","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2026-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}